Skip to main navigation Skip to search Skip to main content

Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways

  • Ali Bagherian
  • , Rajab Mardani
  • , Bostan Roudi
  • , Mohsen Taghizadeh
  • , Hamid Reza Banfshe
  • , Amir Ghaderi
  • , Amirhossein Davoodvandi
  • , Samane Shamollaghamsari
  • , Michael R. Hamblin
  • , Hamed Mirzaei
  • Islamic Azad University
  • Pasteur Institute of Iran
  • Kashan University of Medical Sciences and Health Services
  • Harvard University

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases